Large Outflow of Money Witnessed in St. Jude Medical

St. Jude Medical (STJ) :The total money flow, which is calculated as the dollar value of composite uptick minus downtick trades was negative ($2.8 million) and the uptick to downtick ratio was 0.78. The transaction value on upticks was $10 million and on downticks, the transaction value was $12.8 million. In block trades, the transaction value of inflow done during uptick was $4.02 million. The transaction value of block trades during downticks was $6.14 million. The uptick to downtick block trade ratio was 0.66. The money flow was negative ($2.11 million), indicating the traders were booking profit on the price strength. St. Jude Medical (STJ) rose $0.01 at $80.5, during intraday Monday , a rise of 0.01% over the previous days close.


St. Jude Medical Inc. is up 37.92% in the last 3-month period. Year-to-Date the stock performance stands at 31.7%. St. Jude Medical Inc. has dropped 0.14% in the last five trading days, however, the shares have posted positive gains of 5.42% in the last 4 weeks. In a related news, The officer (VP, Global Quality), of St Jude Medical Inc, Fecho Jeff had unloaded 10,408 shares at $51.71 per share in a transaction on February 5, 2016. The total value of transaction was $538,198. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.

St. Jude Medical (NYSE:STJ): stock turned positive on Monday. Though the stock opened at $80.55, the bulls momentum made the stock top out at $80.59 level for the day. The stock recorded a low of $80.28 and closed the trading day at $80.56, in the green by 0.09%. The total traded volume for the day was 2,458,886. The stock had closed at $80.49 in the previous days trading.

St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.